The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation. [electronic resource]
- Expert review of cardiovascular therapy 2016
- 177-87 p. digital
Publication Type: Journal Article; Review
1744-8344
10.1586/14779072.2016.1116941 doi
Anticoagulants--therapeutic use Atrial Fibrillation--drug therapy Fibrinolytic Agents--therapeutic use Humans International Normalized Ratio Vitamin K--antagonists & inhibitors Warfarin--therapeutic use